Degasperi E, Anolli MP, Uceda Renteria SC, Sambarino D, et al. Bulevirtide monotherapy for 48 Weeks in hdv patients with compensated cirrhosis and clinically significant portal hypertension. J Hepatol 2022 Aug 13. pii: S0168-8278(22)02980.
PMID: 35973578